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Running title: the Incidence of Lead Dislodgement 
 
 
Abstract: Introduction: Leadless cardiac pacemaker (LCP) implantation using a trans-
catheter was recently developed to avoid pocket- and lead-related complications. Although a 
LCP has an active fixation mechanism using tines or a helix, LCP and lead dislodgement 
issues remain a major safety concern for patients. This article reviews the literature to 
determine the incidence of lead and LCP dislodgement.  
Methods and Results: A total of 18 studies which included 17,321 patients undergoing 
conventional single or dual chamber pacemaker implantation and 3 studies which included 
2,116 patients undergoing LCP device implantation were reviewed. The incidence of lead 
dislodgement ranged from 1%–2.69% in individual studies with a mean of 1.63%, weighted 
mean of 1.71%, and median of 1.60%. There was a relatively higher lead dislodgement rate 
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between atrial and ventricular electrodes (OR, 3.56; 95% CI, 1.9–6.70; P = 0.6; I2 = 0%), and 
between MRI conditional and conventional leads (OR, 2.79; 95% CI, 1.30–5.99; P = 0.16; I2 
= 46%). The use of active fixation leads (OR, 1.06; 95% CI, 0.66–1.70; P = 0.29; I2 = 20%) 
showed no significant difference in dislodgement risk compared to passive fixation leads. 
The incidence of LCP device dislodgement was 0%, 0.13% and 1.1% in three leadless 
pacemaker studies.  
Conclusions: The incidence rates of conventional pacemaker lead dislodgement vary in 
individual studies with an overall high incidence. Use of the currently available LCP systems 
appears to result in a lower rate of device dislodgement. This may reflect the effectiveness of 
this novel technology and the fixation design of LCP devices. 
Keywords: Leadless cardiac pacemaker; lead dislodgement; incidence; risk; cardiac 
pacemaker 
Introduction 
Since their introduction in the late 1950s, cardiac pacemaker (PM) and lead technology 
have markedly improved, and include a reduction in generator size and lead diameter, 
increased battery longevity, electrode quality and durability
[1]
. The implantation of 
transvenous endocardial leads is a safe and relatively simple procedure, although effective 
lead placement is still a critical part of the procedure. Nearly one million patients worldwide 
receive transvenous cardiac PMs to treat bradycardia and heart block each year
[2]
. However, 
despite the technological advancements in PMs, lead dislodgement is still one of the most 
common complications.  
  It is known that traditional PM and lead systems are subject to infection and lead 
failure.  To avoid pocket- and lead-related complications, two LCP systems have been 
developed to meet this clinical requirement
[3]
. As the LCP is implanted with a relatively large 
delivery trans-catheter through the femoral vein using active fixation, the device and/or 
electrode dislodgement remains a major safety concern with this new technique.  
       This study aimed to provide a detailed analysis of the available literature on the 
incidence of lead electrode dislodgement with conventional PMs compared with the 
incidence observed in recently published LCP trials. Additionally, reasons for lead and device 
dislodgement were analyzed. 
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Methods 
Study retrieval strategy 
A systematic search of the PubMed, Cochrane Library, and Google Scholar databases 
was performed from 1990–2018. Only full-sized papers in English, published in peer-
reviewed journals reporting detailed data on the most common PM lead-related complications 
were considered. Studies eligible for inclusion were identified using the following search 
strategy: 1st run: “pacemaker,” 2nd run: (dislodgement or dislocation) and “pacemaker.”  
According to the inclusion criteria and exclusion criteria the flow chart of literature selection 
was as follows: 
 
 
 
Inclusion criteria 
The eligibility criteria for this meta-analysis were as follows. (1) Inclusion of patients 
undergoing conventional PM system implantation for standard indications. (2) Pacemaker 
implantation type included: implantation position (atrium and ventricle), fixation type 
(passive vs. active), and lead type (MRI conditional vs. conventional leads). (3) Detailed data 
on the rate of lead dislodgement was reported, defined as inadequate capture and/or sensing, 
or phrenic nerve stimulation with (macro-dislocation) or without (micro-dislocation) a visible 
change in the lead position on chest X-ray. 
Exclusion criteria 
(1) Studies reporting only pooled data for PM, coronary sinus or ICD leads associated 
complications were not considered. (2) Studies using repeated clinical data were not 
considered. (3) Studies or reviews with no  direct data were not considered. 
Data extracted 
The total number of patients, the number of patients with dislodgement, patient 
characteristics, frequency and timing of lead dislodgement, utilized lead and system types and 
rate of dislodgement were extracted from the selected studies. The methodological quality of 
non-controlled studies was assessed using the Methodological Index for Nonrandomized 
Studies (MINORS)
[4]
. Studies were defined to be of low, moderate, or high quality based on 
their MINORS scores of ≤8, 9–16, and ≥17 points, respectively. 
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The methodological quality of randomized controlled studies was assessed using the 
Cochrane risk bias assessment tool. The risk of bias was evaluated mainly from six areas of 
the project team, and judgment was carried out on each indicator using “low bias risk.”, 
“moderate bias risk,” and “high bias risk.” 
Statistical analysis 
Statistical analyses were conducted using R 3.3 (Biostat, Inc., Englewood, NJ, USA) and 
Microsoft Excel 2016 MSO (Microsoft Corp., Redmond, WA, USA). Event rates were 
synthesized using descriptive statistics; minimum and maximum, mean, weighted mean, and 
median incidences were calculated. OR and its 95% confidence intervals (CI) were calculated 
from events and sample sizes for a head-to-head comparison of different systems and lead 
types or lead positions. Heterogeneity between individual trial estimates was assessed using 
the Q statistic and I2 statistic. In the case of I2 index values >50% indicating significant 
heterogeneity, the random-effect model was used, otherwise the fixed-effect model was used. 
Results 
Study characteristics 
A total of 18 studies fulfilled the predefined selection criteria for leads and three studies 
fulfilled the criteria for LCP devices. These studies included 17,321 patients undergoing 
conventional single or dual chamber PM implantation (Fig. 1; Table 1) and 2,046 patients for 
a LCP device (Table 2). Of the identified studies, only one
[7]
 was a randomized controlled 
clinical trial, whereas the remainder were post-hoc analyses of randomized trials,
[17,24] 
or 
observational retrospective
[5,8,16,18,22-23] 
or observational prospective studies
[9-13,14-15,19-21,25]
. 
The vast majority were multicenter studies
[5,12-13,15,17,20-22,24-25]
, with seven single-center 
studies
[9,11,13,16,18-19,23]
. Individual studies used different definitions of lead dislodgement or 
dislocation including signs of elevated pacing thresholds or a decrease in sensing or failure to 
capture, or a visible change in lead position on chest X ray (Tables 1 and 2). 
Lead Dislodgement with Conventional PM Systems 
The incidence of lead dislodgement ranged from 1%–2.69% in individual studies with a 
mean of 1.63%, weighted mean of 1.71%, and median of 1.60% (Fig. 2). In the present 
review, lead dislodgement was the most common complication of conventional PM systems . 
There was a relatively higher lead dislodgement rate with atrial as compared to 
ventricular electrodes (OR, 3.56; 95% CI, 1.9–6.70; P = 0.6; I2 = 0%) and between MRI 
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conditional and conventional leads (OR, 2.79; 95% CI, 1.30–5.99; P = 0.16; I2 = 46%). The 
use of active fixation leads (OR, 1.06; 95% CI, 0.66–1.70; P = 0.29; I 2 = 20%) had no 
significant difference in dislodgement risk compared to that of passive fixation leads.  
Armaganijan’s study[17] demonstrated that elderly patients were at increased risk of peri-
implant complications, particularly lead dislodgement and pneumothorax. The 
development of perioperative complications was more common in patients aged 75 years or 
over (5.1% vs. 3.4%; P = 0.006). 
Device Dislodgement with LCP Systems 
The incidence of LCP device dislodgement was 0%, 0.13% and 1.1%  in three leadless 
pacemaker studies (Fig. 2)
[12,13,25]
. In the second MICRA study, one local device 
dislodgement (without embolization) was noted 2 days post-implant, and in this case, two 
tines were observed to not be embedded in tissues and two tines were positioned between the 
wall and papillary muscle. Fortunately at 50 days post-implant, the same device was 
successfully repositioned, with normal pacing thresholds and no further issues noted at the 
time of repositioning
[12]
. In the Nanostim study, device migration to the pulmonary artery or 
right femoral vein occurred in four and two patients, respectively. There was no significant 
difference in the dislodgement rate between devices positioned in the right ventricular apex 
and those in non-apical positions (P = 0.42) in the total cohort of 526 patients
[13]
.  
Discussion 
Main Findings 
Eighteen studies which included 17,321 patients undergoing conventional single or dual 
chamber PM implantation showed an overall high incidence of lead dislodgement (on 
average >1.5%). In the LCP studies, the dislodgement incidence of MICRA was 0% and 
0.13%, respectively, and the dislodgement incidence of Nanostim was 1.1%. These values 
were all lower than the traditional PM lead dislodgement risk, reflecting the significant 
potential of this new technology. 
Incidence of Lead Dislodgement with Conventional PM Systems 
As shown in Figure 3A, Ghani et al. (2014) reported an atrial electrode dislodgement 
rate that is 7 fold higher than that of ventricular dislodgement. Most studies showed that the 
dislodgement rate of atrial electrodes was slightly higher than that of ventricular electrodes. 
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This may be due to the thin wall and the anatomical location of the right atrial appendage the 
most targeted site for RA lead placement. 
The results in Figure 3B show that the type of lead fixation design also had some 
influence on electrode dislodgement. The rate of lead dislodgement in the active fixation 
design was lower. The active fixation leads, with a screw-in mechanism, conceptually were 
purported to provide more consistent contact with myocardial tissue and prevent 
dislodgement, thus leading to a lower incidence of high pacing threshold or loss of capture 
events. One year follow-up data from Witt et al.
[8] 
 showed that lead dislodgement in the 
active fixation method was similar to that in passive fixation. However, after a 5-year follow-
up period, the rate of lead dislodgement in active fixation was significantly lower than that in 
passive fixation. 
As shown in Figure 3C, the results from Elmouchi et al. demonstrated that the rate of 
MRI conditional lead dislodgement was 13.54 times higher than that of non-MRI-conditional 
lead dislodgement. This may be attributed to the different skill level of the implanter, which 
can result in instability of the electrode implanted. For example, a study reported that two 
implanting physicians both had two lead dislodgements, whereas the remaining three 
electrophysiologists had no dislodgements
[23]
. The higher rate of dislodgement between the 
5086 MRI conditional lead and the 5076 lead may be due to the reduced filar design, the 
slightly increased lead weight and physician learning curve during implantation of this active 
fixation lead
[24]
. 
Device Dislodgement with LCP Systems 
This study showed that dislodgment of LCP occurs at a lower magnitude compared to 
transvenous leads dislodgment. While there is no head to head randomized comparison, it 
appears that dislodgment rate of Micra is lower than Nanostim. Conceivably, the active 
nitinol tines allow a more stable position as compared to the nanostim helix active fixation. 
Targeting at least 2/4 tines for engagement within the myocardium gives the implanting 
physician a visible landmark that helps ensure stability of the pacemaker. 
Limitations 
We did not have access to individual patient data from all the studies reviewed but relied 
on published information.  Furthermore, there were large variations in the follow-up periods, 
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and no long-term follow-up data were available in some of the studies. LCP systems 
represent single-chamber devices only and patient populations were limited; therefore, the 
comparison of complications with dual-chamber systems could be biased. 
Conclusions 
Dislodgement rates of conventional PM leads vary in individual studies with an overall 
high incidence. Use of the currently available LCP systems, appears to result in a lower rate 
of lead dislodgement. This may reflect the effectiveness of this novel technology and the 
design of these devices. A better classification scheme of device dislodgement would be 
advantageous for future research. Despite the lack of long-term data, results from these 
studies showed that leadless pacing therapy is an efficacious and safe alternative to 
conventional pacemakers. 
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Fig.1  Flow chart of the literature search and study selection. 
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Fig 2. Incidence of pacemaker lead dislodgement in different studies. 
 
 
 
 
Fig3.(A) Risk of pacemaker lead dislodgement by lead type (RA vs. RV).(B) Risk of 
pacemaker lead dislodgement by fixation type (passive vs. active).(C) Risk of pacemaker lead 
dislodgement by lead type (MRI conditional vs. conventional leads). 
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TABLE 1 
Characteristics of Conventional Pacemaker Systems in the Included Studies 
Stud
y 
Subjects 
Incid
ence 
Age(
Years
) 
Sex(F
emale) 
Foll
ow-
Up 
Device
s 
Impla
nted 
Rate 
of  
Dislo
dge
ment 
Dislod
gement 
Define
d as 
Qu
alit
y 
To
tal 
Dislod
gement 
Muelle
r et 
al.
14
 
33
7 
5 
1.48
% 
67~75 43% 
16 
mon
ths 
VVI 
77%; 
DDD 
23% 
4/258 
ventricular; 
1/77atrial 
lead 
displaceme
nt 
n.a. 
mod
erate 
Chang  
et al.
5
 
48
2 
13 
2.69
% 
66.6±1
2.8 
56.3% 
30 
days 
n.a. 
RA lead 
dislodgeme
nt 2.48%; 
RV lead 
dislodgeme
nt 0.83%; 
the 
moveme
nt of the 
pacing 
lead 
from its 
originall
y 
implante
d 
position 
resulting 
in 
elevated 
pacing 
threshol
ds or a 
decrease 
in 
sensing. 
 
high 
Facc 
et al.
6
 
48
6 
4 1% 
71.4±1
3.5 
45% 
33 
mon
ths 
DDD 
100% 
n.a. 
lead 
dislodg
ment 
low 
David 
et al.
7
 
20
0 
2 1% 75±10 49.5% 
one 
year 
DDD 
100% 
AF Lead 
dislodgeme
nt (0/97); 
PF Lead 
dislodgeme
nt (2/103) 
Exit 
block 
with a 
rise in 
pacing 
threshol
d above 
the 
safety 
margin 
without 
evidence 
of 
macro-
Low 
Risk 
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dislodge
ment 
Witt et 
al.
8
 
34
51 
68 2% 73.9 46.6% 
1 
year 
dual-
chambe
r 
pacema
ker 
Active 
fixation 
dislodgeme
nt 
2%;Passive 
fixation 
dislodgeme
nt 2.1% 
lead 
dislodg
ment 
high 
Udo et 
al.
15
 
15
17 
24 
1.58
% 
73.7±1
0.8 
44% 
long
-
term 
follo
w-
up 
AAI 
1.5%;V
VI 
25.1%; 
DDD 
73.3% 
14 atrial 
leads 
and 10 right 
ventricular 
leads 
Dislocati
on 
mod
erate 
Link 
et al.
20
 
40
7 
9 
2.21
% 
76±8 31% 
18 
mon
ths 
DDD 
100% 
7 with a 
ventricular 
lead and 2 
with an 
atrial lead 
dislodgeme
nt 
n.a. 
mod
erate 
Gamm
age 
et al.
21
 
33
8 
7 
2.07
% 
70.6±1
1.6 
40% 
3 
mon
ths 
DDD 
100% 
 
Lead 
dislodg
ment 
mod
erate 
Chauh
an 
et al.
9 
20
19 
33 1.6% n.a. 
40~45
% 
6 
wee
ks 
VVI 
85.8%; 
DDD 
14.2% 
18(1 %) 
VVI 
patients and 
15 (5.2%) 
DDD 
patients 
a rise in 
pacing 
threshol
d 
resulting 
in 
failure 
to 
capture 
or a 
visible 
change 
of lead 
position 
on the 
chest X 
ray. 
low 
Trigan
o 
et al.
10
 
11
9 
2 1.6% 69±8 40% 
4 
wee
ks 
DDD 
100% 
lead 
dislodgmen
t of one 
atrial and 
one 
lead 
dislodg
ment 
mod
erate 
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ventricular 
lead 
Aggar
wal 
et al.
11
 
10
59 
15 1.4% 
74.8±1
2.2 
49% 
Up 
to 2 
mon
ths 
AAI 
5.2%; 
VVI 
40.7% ; 
VDD 
54.1%; 
DDD 
100% 
Atrial lead 
displaceme
nt (n = 10, 
1.6%>> 
ventricular 
lead 
displaceme
nt (n = 5, 
0.5% 
electrod
e 
displace
ment 
low 
Armag
anijan 
et al.
17
 
48
18 
80 1.6% 76 43% 
5.1 
year
s 
AAI/V
VI,DD
D 
n.a. 
Lead 
dislodg
ment/ 
Loss of 
capture 
Mod
erate 
risk 
Burri 
et al.
18
 
36
2 
5 
1.38
% 
78±10 39% 
24 
mon
ths 
VVI 
37%, 
DDD 
63% 
n.a. n.a. 
mod
erate 
Ghani 
et al.
19
 
68
5 
13 
1.89
% 
74~78 45% 
1 
year 
AAI/V
VI 
38%; 
DDD 
62% 
Right atrial 
dislodgeme
nt (1.9 %; 
right 
ventricular 
dislodgeme
nt (0.3 % 
A 
change 
in the 
lead tip 
position 
on chest 
X-ray 
and 
changes 
in 
electrica
l lead 
paramet
ers 
high 
Kivini
emi 
et al.
16
 
44
6 
8 
1.79
% 
72±13 59% 
27+-
20 
mon
ths 
AAI 
19%;V
VI 
55%;V
DD 
3%;DD
D 23% 
Dislodgeme
nt of atrial 
lead 
6(3.3%); 
ventricular 
lead 
2(0.6%) 
 
mod
erate 
Palmis
ano 
et al.
22
 
95
9 
13 
1.35
% 
n.a. n.a. 
27 
mon
ths 
AAI/V
VI 
21%; 
DDD 
79% 
n.a. n.a. 
mod
erate 
Elmou
chi 
et al.
23
 
15
7 
4 
2.55
% 
68.9~7
4.8 
45%~4
7% 
30 
days 
DDD 
100% 
Three of 
the lead 
dislodgeme
nts were 
atrial and 
one was 
n.a. high 
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ventricular. 
Richar
d 
et al.
24
 
78
2 
14 
1.79
% 
65.3~7
0.3 
55~62
% 
9.6~
30.8 
mon
ths 
DDD,C
RT 
n.a. n.a. 
Low 
risk 
 
 
TABLE 2 
Characteristics of Leadless Pacemaker Systems in the Included Studies 
Study 
Subjects(N) 
Inciden
ce 
Age(Yea
rs) 
Sex(Fema
le) 
Follo
w-Up 
Devices 
Implant
ed 
Dislodgem
ent 
Defined as 
Quali
ty 
Tot
al 
Dislodg
e-ment 
Reynol
ds 
et al.
25
 
725 0 0 
75.9±10.
9 
41.2% 1 year 
Micra 
TPS 
No 
dislodgeme
nt 
high 
Roberts 
et al.
12
 
795 1 0.13% 
75.2±14.
2 
62.3% 
1 
month
s 
Micra 
TPS 
 
2 tines 
were 
observed to 
not 
be 
embedded 
in tissue 
and 2 
tines were 
positioned 
between the 
wall and 
papillary 
muscle 
high 
Reddy 
et al.
13
 
526 6 1.1% 
75.8±12.
1 
385 
6.9+-
4.2 
month
s 
Nanosti
m-LCP 
 
 
Device 
migration 
to the 
pulmonary 
artery or 
right 
femoral 
vein 
occurred in 
4 and 2 
patients, 
respectivel
y. 
high 
 
 
